53BP1, an activator of ATM in response to DNA damage

DNA Repair

Volumn 3, Issue 8-9, 2004, Pages 945-952

  Mochan, Tamara A ^a,b   Venere, Monica ^a,b   DiTullio Jr , Richard A ^a,b   Halazonetis, Thanos D ^a,b  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

53BP1; ATM; Chk2; Nbs1; NFBD1 MDC1; p53

Indexed keywords

DNA; PROTEIN P53; PROTEIN RAD9;

BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; DNA DAMAGE; GENE LOCATION; GENE MUTATION; MOLECULAR EVOLUTION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION;

ANIMALS; BINDING SITES; CELL CYCLE PROTEINS; DNA; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FIBROBLASTS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

SACCHAROMYCETALES;

EID: 3242884087     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2004.03.017     Document Type: Review

References (56)

1. Iwabuchi K., Bartel P.L., Li B., Marraccino R., Fields S. Two cellular proteins that bind to wild-type but not mutant p53. Proc. Natl. Acad. Sci. U.S.A. 91:1994;6098-6102
2. Chen J., Marechal V., Levine A.J. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell Biol. 13:1993;4107-4114
3. Seto E., Usheva A., Zambetti G.P., Momand J., Horikoshi N., Weinmann R., Levine A.J., Shenk T. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. U.S.A. 89:1992;12028-12032
4. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature. 408:2000;307-310
5. Iwabuchi K., Li B., Massa H.F., Trask B.J., Date T., Fields S. Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2. J. Biol. Chem. 273:1998;26061-26068
6. Joo W.S., Jeffrey P.D., Cantor S.B., Finnin M.S., Livingston D.M., Pavletich N.P. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev. 16:2002;583-593
7. Derbyshire D.J., Basu B.P., Serpell L.C., Joo W.S., Date T., Iwabuchi K., Doherty A.J. Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor. EMBO J. 21:2002;3863-3872
8. Ponting C.P. Tudor domains in proteins that interact with RNA. Trends Biochem. Sci. 22:1997;51-52
9. Selenko P., Sprangers R., Stier G., Buhler D., Fischer U., Sattler M. SMN tudor domain structure and its interaction with the Sm proteins. Nat. Struct. Biol. 8:2001;27-31
10. Sprangers R., Groves M.R., Sinning I., Sattler M. High-resolution X-ray and NMR structures of the SMN Tudor domain: conformational variation in the binding site for symmetrically dimethylated arginine residues. J. Mol. Biol. 327:2003;507-520
11. Maurer-Stroh S., Dickens N.J., Hughes-Davies L., Kouzarides T., Eisenhaber F., Ponting C.P. The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem. Sci. 28:2003;69-74
12. Bork P., Hofmann K., Bucher P., Neuwald A.F., Altschul S.F., Koonin E.V. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11:1997;68-76
13. Manke I.A., Lowery D.M., Nguyen A., Yaffe M.B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science. 302:2003;636-639
14. Yu X., Chini C.C., He M., Mer G., Chen J. The BRCT domain is a phospho-protein binding domain. Science. 302:2003;639-642
15. Schultz L.B., Chehab N.H., Malikzay A., Halazonetis T.D. p53 Binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J. Cell Biol. 151:2000;1381-1390
16. Weinert T.A., Hartwell L.H. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science. 241:1988;317-322
17. Emili A. MEC1-dependent phosphorylation of Rad9p in response to DNA damage. Mol. Cell. 2:1998;183-189
18. Vialard J.E., Gilbert C.S., Green C.M., Lowndes N.F. The budding yeast Rad9 checkpoint protein is subjected to Mec1/Tel1-dependent hyperphosphorylation and interacts with Rad53 after DNA damage. EMBO J. 17:1998;5679-5688
19. Sun Z., Hsiao J., Fay D.S., Stern D.F. Rad53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpoint. Science. 281:1998;272-274
20. Gilbert C.S., Green C.M., Lowndes N.F. Budding yeast Rad9 is an ATP-dependent Rad53 activating machine. Mol. Cell. 8:2001;129-136
21. Willson J., Wilson S., Warr N., Watts F.Z. Isolation and characterization of the Schizosaccharomyces pombe rhp9 gene: a gene required for the DNA damage checkpoint but not the replication checkpoint. Nucleic Acids Res. 25:1997;2138-2146
22. Saka Y., Esashi F., Matsusaka T., Mochida S., Yanagida M. Damage and replication checkpoint control in fission yeast is ensured by interactions of Crb2, a protein with BRCT motif, with Cut5 and Chk1a. Genes Dev. 11:1997;3387-3400
23. Xia Z., Morales J.C., Dunphy W.G., Carpenter P.B. Negative cell cycle regulation and DNA damage-inducible phosphorylation of the BRCT protein 53BP1. J. Biol. Chem. 276:2001;2708-2718
24. Anderson L., Henderson C., Adachi Y. Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage. Mol. Cell Biol. 21:2001;1719-1729
25. Rappold I., Iwabuchi K., Date T., Chen J. Tumor suppressor p53 binding protein (1 53BP1) is involved in DNA damage-signaling pathways. J. Cell Biol. 153:2001;613-620
26. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273:1998;5858-5868
27. Rogakou E.P., Boon C., Redon C., Bonner W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146:1999;905-916
28. Maser R.S., Monsen K.J., Nelms B.E., Petrini J.H. hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol. Cell Biol. 17:1997;6087-6096
29. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer. 3:2003;155-168
30. Wang B., Matsuoka S., Carpenter P.B., Elledge S.J. 53BP1, a mediator of the DNA damage checkpoint. Science. 298:2002;1435-1438
31. DiTullio R.A. Jr., Mochan T.A., Venere M., Bartkova J., Sehested M., Bartek J., Halazonetis T.D. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat. Cell Biol. 4:2002;998-1002
32. Fernandez-Capetillo O., Chen H.T., Celeste A., Ward I., Romanienko P.J., Morales J.C., Naka K., Xia Z., Camerini-Otero R.D., Motoyama N., Carpenter P.B., Bonner W.M., Chen J., Nussenzweig A. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat. Cell Biol. 4:2002;993-997
33. Ward I.M., Minn K., van Deursen J., Chen J. p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol. Cell Biol. 23:2003;2556-2563
34. Morales J.C., Xia Z., Lu T., Aldrich M.B., Wang B., Rosales C., Kellems R.E., Hittelman W.N., Elledge S.J., Carpenter P.B. Role for the BRCA1 C-terminal repeats (BRCT) protein 53BP1 in maintaining genomic stability. J. Biol. Chem. 278:2003;14971-14977
35. Celeste A., Fernandez-Capetillo O., Kruhlak M.J., Pilch D.R., Staudt D.W., Lee A., Bonner R.F., Bonner W.M., Nussenzweig A. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat. Cell Biol. 5:2003;675-679
36. Ward I.M., Minn K., Jorda K.G., Chen J. Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX. J. Biol. Chem. 278:2003;19579-19582
37. Du L.L., Nakamura T.M., Moser B.A., Russell P. Retention but not recruitment of Crb2 at double-strand breaks requires Rad1 and Rad3 complexes. Mol. Cell Biol. 23:2003;6150-6158
38. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature. 421:2003;961-966
39. Goldberg M., Stucki M., Falck J., D'Amours D., Rahman D., Pappin D., Bartek J., Jackson S.P. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature. 421:2003;952-956
40. Mochan T., Venere M., DiTullio R.A. Jr., Halazonetis T.D. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating Ataxia-Telangiectasia Mutated (ATM) in response to DNA damage. Cancer Res. 63:2003;8586-8591
41. Iwabuchi K., Basu B.P., Kysela B., Kurihara T., Shibata M., Guan D., Cao Y., Hamada T., Imamura K., Jeggo P.A., Date T., Doherty A.J. Potential role for 53BP1 in DNA end-joining repair through direct interaction with DNA. J. Biol. Chem. 278:2003;36487-36495
42. Zhang Y., Reinberg D. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 15:2001;2343-2360
43. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 421:2003;499-506
44. Shang Y.L., Bodero A.J., Chen P.L. NFBD1, a novel nuclear protein with signature motifs of FHA and BRCT, and an internal 41-amino acid repeat sequence, is an early participant in DNA damage response. J. Biol. Chem. 278:2003;6323-6329
45. Xu X., Stern D.F. NFBD1/KIAA0170 is a chromatin-associated protein involved in DNA damage signaling pathways. J. Biol. Chem. 278:2003;8795-8803
46. Lou Z., Minter-Dykhouse K., Wu X., Chen J. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature. 421:2003;957-961
47. Yarden R.I., Pardo-Reoyo S., Sgagias M., Cowan K.H., Brody L.C. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Genet. 30:2002;285-289
48. Scully R., Chen J., Plug A., Xiao Y., Weaver D., Feunteun J., Ashley T., Livingston D.M. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell. 88:1997;265-275
49. Liu C.Y., Flesken-Nikitin A., Li S., Zeng Y., Lee W.H. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 10:1996;1835-1843
50. Uziel T., Lerenthal Y., Moyal L., Andegeko Y., Mittelman L., Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22:2003;5612-5621
51. Carson C.T., Schwartz R.A., Stracker T.H., Lilley C.E., Lee D.V., Weitzman M.D. The Mre11 complex is required for ATM activation and the G(2)/M checkpoint. EMBO J. 22:2003;6610-6620
52. Yazdi P.T., Wang Y., Zhao S., Patel N., Lee E.Y., Qin J. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev. 16:2002;571-582
53. Lim D.S., Kim S.T., Xu B., Maser R.S., Lin J., Petrini J.H., Kastan M.B. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature. 404:2000;613-617
54. Buscemi G., Savio C., Zannini L., Micciche F., Masnada D., Nakanishi M., Tauchi H., Komatsu K., Mizutani S., Khanna K., Chen P., Concannon P., Chessa L., Delia D. Chk2 activation dependence on Nbs1 after DNA damage. Mol. Cell Biol. 21:2001;5214-5222
55. Kraulis P. Molscript: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:1991;946-950
56. Merritt E.A., Bacon D.J. Raster 3D-photorealistic molecular graphics. Methods Enzymol. 277:1997;505-524